PROTEIN FROM SV40 RECOMBINANTS
US Application 06/309,110
Filed on 1981-10-06
Filed on 1981-10-06
SIMIAM VIRUS RECOMBINANT THAT DIRECTS THE SYNTHESIS OF HEPATITIS B SURFACE ANTIGEN
US Patent 4,442,205
Filed on 1981-09-22
Filed on 1981-09-22
Poly (ICL) as an Effective Interferon Inducer
US Application 06/292,583
Filed on 1981-08-13
Filed on 1981-08-13
Neisseria Gonorrhoeae Vaccine
US Patent 4,443,431
Filed on 1981-05-27
Filed on 1981-05-27
TICK CELL LINES
US Patent 4,447,537
Filed on 1981-01-22
Filed on 1981-01-22
CULTIVATABLE HUMAN ROTAVIRUS TYPE 2
US Patent 4,341,870
Filed on 1980-11-19
Filed on 1980-11-19
Modification of Hepatitis B Virus Infection in Chronic Carriers of Hepatitis B Surface Antigen
US Patent 4,140,761
Filed on 1977-04-11
Filed on 1977-04-11
NUCLEASE-RESISTANT HYDROPHILIC COMPLEX OF POLYRIBOINOSINIC-POLYRIBOCYTIDTYLIC ACID
US Patent 3,952,097
Filed on 1974-09-27
Filed on 1974-09-27
Novel Protein for Development of a Chlamydial Vaccine
BIO 2007 Innovation Corridor “Best Poster” Award
The poster presented by Anna Z. Amar, Technology Development Associate, National Institute of Allergy and Infectious Diseases (NIAID), NIH – for a Novel Protein for Development of a Chlamydial Vaccine – was awarded “Best Poster” at the BIO 2007 Convention.
Mast Cell Line for Research on Allergies and Inflammatory Diseases
Reactive mast cells are the culprit in allergic diseases and have also been implicated in other diseases ranging from autoimmune disorders to cancer to atherosclerosis. These immune sentinel cells normally defend against parasites and bacteria, but sometimes they overreact to harmless intruders, such as pollens or plant oils, releasing granules loaded with inflammation-inciting molecules, such as histamine, as well as various proteases and cytokines that cause allergic and inflammatory reactions.